<DOC>
	<DOCNO>NCT01460238</DOCNO>
	<brief_summary>The investigator hypothesize Lipoprotein Lipase ( LPL ) expression Chronic Lymphocytic Leukemia ( CLL ) cell predict aggressive clinical course . The result proposal validate use novel antibody develop Dartmouth-Hitchcock CLL predict CLL patient aggressive form disease . The investigator work also provide direct evidence LPL express CLL cell provide critical source fatty acid require CLL cell grow survive . Fatty acid metabolism may become therapeutic target CLL future .</brief_summary>
	<brief_title>Lipoprotein Lipase Expression Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>The investigator plan use novel antibody develop Dartmouth-Hitchcock Medical Center characterize expression LPL CLL . Peripheral blood CLL patient analyze flow cytometry detect expression LPL investigate LPL expression correlate aggressive type CLL . The investigator propose LPL protein expression CLL cell prognostic LPL proteins involve fatty acid metabolism critical CLL cell survive .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Diagnosis CLL per National Cancer Institute Working Group Guidelines Patients undergoing routine blood draw part ongoing follow CLL 18 year old Ability provide consent English Patient must measurable disease define absolute lymphocyte count great 5,000/mm3 archive lymph node bone marrow CLL involvement . Patients receive cytotoxic drug , oral intravenous steroid target antibody therapy CLL , hematologic malignancy disease process within past 6 month exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Lipoprotein Lipase</keyword>
	<keyword>Chronic Lymphocytic Leukemia</keyword>
	<keyword>CLL</keyword>
</DOC>